DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings.ILMN shares are climbing with conviction. Watch the momentum hereThe DNA sequencing company reported adjusted earnings of $1.34 per share, beating the consensus of $1.17.The company, in its prepared remarks, said the performance reflects the momentum in the clinical markets, where sequencing consumables revenue grew at a high single-digit rate year-over-year.The sales reached $1.084 bil ...